| Literature DB >> 29988173 |
Concepción Ramírez1,2, Froylán Ibarra1, Herminia I Pérez2, Norberto Manjarrez2, Héctor J Salgado3, Lucía Ortega2.
Abstract
Rhipicephalus (Boophilus) microplus is a tick that causes huge economic losses in cattle. The indiscriminate use of acaricides has generated resistance to most compounds present on the market. Carvacrol and salicylic acid have been widely studied for their biological activities and have been evaluated in different strains of Rhipicephalus. In this research the analogues carvacrol and salicylic acid were evaluated in larvae of R. (B.) microplus with data obtained in larval packet test (LPT) and larval immersion test (LIT). A lethal concentration 50 (LC50) was assessed. The most potent compounds were evaluated in the adult ticks since there are no reports of evaluation in the life state of the parasite. From all the tested compounds, the ethyl 2-methoxybenzoate (91.82 ± 1.66%, 0.91 μmol/mL) and ethyl 2,5-dihydroxybenzoate (89.14 ± 1.61%, 2.04 μmol/mL) showed the highest percentage of mortality and the lowest LC50. They were found to be the best candidates for a study in vivo.Entities:
Keywords: Acaricidal activity; Carvacrol; Rhipicephalus (Boophilus) microplus; Salicylic acid
Year: 2016 PMID: 29988173 PMCID: PMC5991821 DOI: 10.1016/j.parepi.2016.02.006
Source DB: PubMed Journal: Parasite Epidemiol Control ISSN: 2405-6731
Fig. 1Analogues of Carvacrol: carvacrol acetate (1) and carvacrol methyl ether (2).
Fig. 2Analogues of Salicylic acid: 2,5-dihydroxybenzoic acid (3), methyl 2,5-dihydroxybenzoate (4), ethyl 2,5-dihydroxybenzoate (5), 2-(α,α’-dimethoxymethyl)phenol (6), ethyl 2-methoxybenzoate (7), alcohol 2-hydroxybenzyl (8), methyl p-hydroxybenzoate (9) and propyl p-hydroxybenzoate (10).
Percentage mortality of analogues on R. (B.) microplus larvae in vitro by LPT.
| Conc. % | Carvacrolb | carvacrol acetate (1)d | carvacrol methyl ether (2)d | methyl 2,5-dihydroxybenzoate (4)c | ethyl 2,5-dihydroxybenzoate (5)e | 2 - (α, α’-dimethoxymethyl) phenol (6)a | ethyl 2-methoxybenzoate (7)e |
|---|---|---|---|---|---|---|---|
| 1 | 35.85 ± 3.18 | 67.83 ± 2.07 | 71.69 ± 01.57 | 46.49 ± 0.78 | 89.14 ± 1.61 | 26.29 ± 2.46 | 91.82 ± 1.66 |
| 0.5 | 31.51 ± 3.30 | 46. 77 ± 16.65 | 59.41 ± 01.64 | 43.90 ± 0.61 | 73.94 ± 4.82 | 21.92 ± 2.66 | 80.67 ± 0.46 |
| 0.25 | 27.75 ± 3.95 | 45.42 ± 00.26 | 57.06 ± 18.82 | 38.46 ± 0.59 | 66.30 ± 1.63 | 16.38 ± 1.40 | 83.81 ± 159 |
| 0.125 | 20. 20 ± 3.95 | 46.38 ± 00.32 | 31.20 ± 02.61 | 25.26 ± 03. 48 | 44.69 ± 0.36 | 13.12 ± 1.03 | 73.37 ± 3.65 |
| 0.0625 | 14.52 ± 3.28 | 36.48 ± 01.90 | 17.56 ± 03.18 | 21.61 ± 05.09 | 44.94 ± 1.13 | 10.02 ± 0.13 | 46. 98 ± 10.69 |
Different letters indicate significant difference (p < 0.05).
Percentage mortality of analogues on R. (B.) microplus larvae in vitro by LIT.
| Conc. % | Salicylic Acid calculated e | Salicylic Acid reported a | 2, 5-dihydroxybenzoic acid (3)c | 2-hydroxybenzyl alcohol (8 )b | methyl | propyl |
|---|---|---|---|---|---|---|
| 1 | 92.62 ± 6.17 | 0 | 27.62 ± 5.42 | 15.96 ± 2.98 | 79.31 ± 7.52 | 34.14 ± 4.33 |
| 0.5 | 12.88 ± 1.32 | 1.08 ± 1.55 | 13.68 ± 3.06 | 1.89 ± 0.78 | 49.47 ± 7.34 | 10.71 ± 1.28 |
| 0.25 | 0 | 0.64 ± 1.05 | 2.18 ± 0.84 | 0 | 15.50 ± 2.97 | 0 |
| 0.125 | 0 | 0 | 0 | 0 | 4.21 ± 1.22 | 0 |
| 0.0625 | 0 | 0 | 0 | 0 | 1.19 ± 0.49 | 0 |
* Results reported by Silveira et al., 2007.
Different letters indicate significant difference (p < 0.05).
LC50 of each compound evaluated in larvae R. (B.) microplus in vitro.
| Compound | LC50 (μmol/mL) |
|---|---|
| 59.72 | |
| 6.00 | |
| 5.01 | |
| 35.69 | |
| 2.04 | |
| 30.32 | |
| 333.13 | |
| 0.91 | |
| 11.61 |
Cannot compute (insufficient data).
Mean results for ovoposition reduction (OR), of carvacrol, salicylic acid and analogues.
| Conc. (ppm/mL) | Carvacrol | Salicylic acid | carvacrol methyl ether (1) | carvacrol acetate (2) | ethyl 2,5-dihydroxybenzoate (5) | ethyl 2-methoxybenzoate (7) |
|---|---|---|---|---|---|---|
| 250 | 15.71 ± 3.26 | -1.26 ± 3.19 | 26.72 ± 1.06 | 25.80 ± 0.27 | 26.56 ± 1.07 | 27.00 ± 1.50 |
| 200 | 6.48 ± 4.26 | -1.89 ± 0.98 | 23.59 ± 1.22 | 21.42 ± 3.12 | 21.45 ± 3.02 | 24.60 ± 2.64 |
| 150 | 0.02 ± 1.45 | -11.05 ± 5.7 | 20.29 ± 1.99 | 11.30 ± 1.52 | 14.02 ± 2.398 | 22.33 ± 8.91 |
| 100 | 0.09 ± 2.36 | -8.76 ± 2.93 | 16.03 ± 3.06 | 6.85 ± 0.49 | 7.20 ± 3.20 | 13.91 ± 2.43 |
| 50 | -2.62 ± 1.21 | -7.27 ± 7.39 | 11.13 ± 2.39 | 2.34 ± 1.57 | 6.20 ± 0.2 | 11.21 ± 0.68 |
Mean results for hatching inhibition rate (HR), of carvacrol, salicylic acid and analogues.
| Conc. (ppm/mL) | Carvacrol | Salicylic acid | carvacrol methyl ether (1) | carvacrol acetate (2) | ethyl 2,5-dihydroxybenzoate (5) | ethyl 2-methoxybenzoate (7) |
|---|---|---|---|---|---|---|
| 250 | 7.95 ± 0.37 | 7.09 ± 1.71 | 12.90 ± 0.42 | 10.95 ± 0.47 | 15.59 ± 1.07 | 13.52 ± 0.75 |
| 200 | 8.17 ± 1.49 | 6.19 ± 2.39 | 11.65 ± 0.28 | 9.15 ± 0.51 | 11.22 ± 1.42 | 10.84 ± 0.89 |
| 150 | 6.93 ± 1.97 | 5.69 ± 2.49 | 10.29 ± 0.23 | 7.75 ± 0.63 | 8.81 ± 0.36 | 9.82 ± 0.73 |
| 100 | 5.26 ± 1.36 | 3.99 ± 1.31 | 9.03 ± 1.06 | 6.71 ± 0.81 | 7.01 ± 0.65 | 8.11 ± 0.50 |
| 50 | 0.26 ± 0.28 | 0.52 ± 0.21 | 8.30 ± 0.74 | 6.03 ± 0.84 | 6.43 ± 0.92 | 6.81 ± 0.40 |
Mean results for acaricidal efficacy percentage (E), of carvacrol, salicylic acid and analogues.
| Conc. (ppm/mL) | Carvacrol | Salicylic acid | carvacrol methyl ether (1) | carvacrol acetate (2) | ethyl 2,5-dihydroxybenzoate (5) | ethyl 2-methoxybenzoate (7) |
|---|---|---|---|---|---|---|
| 250 | 16.76 ± 2.27 | 1.11 ± 2.22 | 26.76 ± 1.12 | 26.33 ± 0.19 | 27.29 ± 0.75 | 27.97 ± 1.05 |
| 200 | 9.36 ± 2.97 | -1.31 ± 0.68 | 23.33 ± 0.85 | 22.50 ± 2.17 | 22.77 ± 2.10 | 24.21 ± 1.84 |
| 150 | 0.98 ± 1.01 | -7.86 ± 3.97 | 21.88 ± 1.39 | 11.22 ± 1.05 | 15.36 ± 15.36 | 17.97 ± 6.20 |
| 100 | 1.26 ± 1.64 | -6.47 ± 2.04 | 18.26 ± 2.13 | 7.45 ± 0.34 | 6.81 ± 2.23 | 15.77 ± 1.69 |
| 50 | -2.26 ± 0.84 | -8.12 ± 5.14 | 11.53 ± 1.66 | 2.98 ± 1.10 | 6.68 ± 0.14 | 11.87 ± 0.47 |